NCT01378858View on ClinicalTrials.gov

Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Tobacco Use DisorderMedication Adherence
Interventions
DRUG

Varenicline

Varenicline, titrated to 1 mg twice daily, will be given to participants in both study arms for 12 weeks.

Trial Locations (1)

10467

Albert Einstein College of Medicine, The Bronx

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Albert Einstein College of Medicine

OTHER

NCT01378858 - Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients | Biotech Hunter | Biotech Hunter